Ranking results:

Past rankings:

2019
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
2012
Criterium:	Position:
Overall Score:	900-1000
Total Project Funding per Partner:	800-900
Total Number of Projects:	70
Total Project Funding:	> 1000
Networking Rank (Reputation):	> 1000
Networking Rank (Reputation):	> 1000
Partner Constancy:	46
Project Leadership Index:	75
Diversity Index:	60
2011
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
Total Project Funding:	> 1000
Networking Rank (Reputation):	> 1000
Partner Constancy:	> 1000
Project Leadership Index:	> 1000
Diversity Index:	> 1000
2007
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2022	0	6.348.927	393.128		1
2019	0	6.761.834	243.750		1
2012	0	5.996.180	646.450		1
2011	0	4.849.981	168.237		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	2
KAROLINSKA INSTITUTE	2
THE UNIVERSITY OF EDINBURGH	2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM	1
AGENCE FRANCAISE DE SECURITE SANITAIRE DES ALIMENTS	1
ANAXOMICS BIOTECH S L	1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS	1
BILKENT UNIVERSITESI	1
BRUNEL UNIVERSITY LONDON	1
CAMBRIDGE CELL NETWORKS	1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	1
DEPARTMENT OF HEALTH	1
DEUTSCHES FORSCHUNGSZENTRUM FUR KUNSTLICHE INTELLIGENZ	1
EMULATE INC	1
EUROPEAN RESEARCH AND PROJECT OFFICE	1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA	1
FORSCHUNGSGESELLSCHAFT FUR ARBEITSPHYSIOLOGIE UND ARBEITSSCHUTZ E V	1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA	1
FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA	1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO PUERTA DE HIERROMAJADAHONDA	1
FUNDACION PUBLICA ANDALUZA PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD	1
HEPART MEDICAL DEVICES BV	1
HOFFMANN SEBASTIAN	1
HOSPITAL CLINIC DE BARCELONA	1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	1
INSILICO BIOTECHNOLOGY	1
INSTITUT NATIONAL DE RECHERCHE ENINFORMATIQUE ET AUTOMATIQUE	1
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT	1
IZMIR BIYOTIP VE GENOM MERKEZI	1
LINKOPINGS UNIVERSITET	1
PHARMACELL BV	1
SERVICIO ANDALUZ DE SALUD	1
SERVICIO CANTABRO DE SALUD	1
SERVICIO MADRILENO DE SALUD	1
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS	1
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA	1
UMEA UNIVERSITET	1
UNIVERSIDAD COMPLUTENSE DE MADRID	1
UNIVERSIDAD DE MALAGA	1
UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE	1
UNIVERSIDADE NOVA DE LISBOA	1
UNIVERSITAET DES SAARLANDES	1
UNIVERSITE DE RENNES I	1
UNIVERSITEIT MAASTRICHT	1
UNIVERSITEIT UTRECHT	1
UNIVERSITY OF CAMBRIDGE	1
UNIVERSITY OF GLASGOW	1
VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK NV	1
WEIZMANN INSTITUTE OF SCIENCE	1

Constancy:

Total number of partners: 53
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 53
Frequent / Rare Partner Ratio: 0

Project overview:

Start date	Project	acronym	role	funding	partners
2022-12-01	Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies	halt-RONIN	participant	6.348.927	23
2019-01-01	Beating Goliath: Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds	GOLIATH	participant	6.761.834	16
2012-06-01	Development of a bioartificial liver therapy in acute liver failure	BALANCE	participant	5.996.180	5
2011-01-01	Predicting long-term toxic effects using computer models based on systems characterization of organotypic cultures	NOTOX	participant	4.849.981	13

Alias institution names:

BIOPREDIC INTERNATIONAL SARL

BIOPREDIC INTERNATIONAL SARL - France